Mendez-Pena, Javier E <br/><br/>
RNA chromogenic in situ hybridization assay with clinical automated platform is a sensitive method in detecting high-risk human papillomavirus in squamous cell carcinoma.  [electronic resource] 

 -  Human pathology  05 2017 
 - 184-189 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>1532-8392 
<br/><br/><label>Standard No.: </label>10.1016/j.humpath.2017.02.021  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Automation, Laboratory<br/>Biomarkers, Tumor--analysis<br/>Biopsy<br/>Carcinoma, Squamous Cell--chemistry<br/>DNA Probes, HPV<br/>Female<br/>Fixatives<br/>Formaldehyde<br/>Head and Neck Neoplasms--chemistry<br/>Human Papillomavirus DNA Tests<br/>Humans<br/>Immunohistochemistry<br/>In Situ Hybridization--standards<br/>Male<br/>Middle Aged<br/>Molecular Diagnostic Techniques--standards<br/>Papillomaviridae--genetics<br/>Papillomavirus Infections--pathology<br/>Paraffin Embedding<br/>Polymerase Chain Reaction<br/>Predictive Value of Tests<br/>RNA Probes<br/>RNA, Viral--genetics<br/>Reproducibility of Results<br/>Squamous Cell Carcinoma of Head and Neck<br/>Tissue Fixation--methods<br/>Young Adult